As systems become increasingly interconnected, we talk more and more about the importance of data and, more specifically, the need to get data to the right people, in the right format, at the right time, wherever they may be. This initiative has become even more...
There are lots of reasons why aging, legacy automation systems can be barriers to effective digital transformation. The most obvious reason is that legacy systems are typically complex to connect to new analytics systems, as those systems are rarely designed for...
Melissa Lee & Kebra Tynan join Jim Cahill in this podcast to discuss how Emerson is helping Life Sciences manufacturers address drug development lifecycle challenges with a software-as-a-service (SaaS) based workflow management solution.
Today’s most successful organizations are facing a wide variety of new challenges: a need for increased flexibility, a push toward more sustainable operations, a shrinking experienced workforce, and more. Meeting those challenges will require unlocking the next...
We finally got our wish. Industry 4.0 delivered a wide array of new technologies—sensors, edge devices, mobile devices, and more—that now collect, and sometimes deliver, massive amounts of data from every asset imaginable. However, that leaves a lot of organizations...
Several of our recent Life Sciences podcasts have featured conversations about the rapid shifts taking place in this dynamic industry. Automation and information management technology are rapidly advancing to help address these challenges. In a recent Emerson...
Johan Zebib joins Jim Cahill in an Emerson Automation Experts podcast to share how MES addresses many of the challenges for higher quality, and more efficient and reliable production in the pharmaceutical & biopharmaceutical manufacturing industries.
Hopefully by now you’ve had some fun playing around with some of the many Generative AI tools available for free across the internet. Whether you’ve asked ChatGPT to write some poetry for Mother’s Day or tested out the powerful image rendering capabilities of...
In the life sciences, bringing treatments to market quicker is no longer a bonus. Today, accelerating the treatment development pipeline is an expectation—arguably a core value—of the world’s most respected pharmaceutical companies. The pipeline for the COVID vaccine...
The life sciences industry is changing rapidly. Where once companies were focused on developing blockbuster treatments and manufacturing them as quickly and safely as possible, today, personalized medicine has changed that landscape. Now life sciences companies are...
As the landscape of pharmaceutical manufacturing has changed in the last few years, one exciting shift has a distinct possibility of being a game changer in coming decades. Regulatory agencies have increasingly begun to recognize the importance of automation...
Bill Carey joins Jim Cahill to discuss the Life Sciences Showroom facility in the Austin, Texas area. The showroom demonstrates how to address the challenges in developing a path forward.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.